The Hard Truth About Drug Development--R&D Success Rates

A deep dive into 2,092 drug development projects and nearly 20,000 clinical trials from 18 top pharmaceutical companies reveals a 14.3% success rate from Phase 1 to approval&mdash;a slight uptick from previous estimates (~10%), but hardly a game-changer. Whether this reflects true R&amp;D efficiency gains or just statistical noise, one thing remains clear: drug development is still a brutal numbers game.
Success in the Lab &ne; Success in the Market